Zdrowie i gospodarka · 06/05/2024

FDA Announces Draft Guidance for In Vitro Diagnostic Devices in Response to CBRN Threats

The FDA is releasing a draft guidance on the enforcement policy for certain in vitro diagnostic devices in emergency situations involving chemical, biological, radiological, or nuclear threats, without a declaration under Section 564.